Ratto-Kim S - Search Results

1

Varicella immunity: persistent serologic non-response to immunization.

Katial RK, Ratto-Kim S, Sitz KV, Moriarity R, Engler RJ. Katial RK, et al. Ann Allergy Asthma Immunol. 1999 May;82(5):431-4. doi: 10.1016/S1081-1206(10)62716-0. Ann Allergy Asthma Immunol. 1999. PMID: 10353572

2

Expansion of restricted cellular immune responses to HIV-1 envelope by vaccination: IL-7 and IL-12 differentially augment cellular proliferative responses to HIV-1.

Kim JH, Loveland JE, Sitz KV, Ratto Kim S, Mclinden RJ, Tencer K, Davis K, Burke DS, Boswell RN, Redfield RR, Birx DL. Kim JH, et al. Clin Exp Immunol. 1997 May;108(2):243-50. doi: 10.1046/j.1365-2249.1997.d01-1006.x. Clin Exp Immunol. 1997. PMID: 9158092 Free PMC article. Clinical Trial.

3

Delayed-type hypersensitivity skin testing using third variable loop peptides identifies T lymphocyte epitopes in human immunodeficiency virus-infected persons.

Sitz KV, Loomis-Price LD, Ratto-Kim S, Kenner JR, Sau P, Eckels KH, Redfield RR, Birx DL. Sitz KV, et al. J Infect Dis. 1997 Oct;176(4):1085-9. doi: 10.1086/516517. J Infect Dis. 1997. PMID: 9333173

4

Proliferative responses to human immunodeficiency virus type 1 (HIV-1) gp120 peptides in HIV-1-infected individuals immunized with HIV-1 rgp120 or rgp160 compared with nonimmunized and uninfected controls.

Sitz KV, Ratto-Kim S, Hodgkins AS, Robb ML, Birx DL. Sitz KV, et al. J Infect Dis. 1999 Apr;179(4):817-24. doi: 10.1086/314685. J Infect Dis. 1999. PMID: 10068576 Clinical Trial.

5

Repeated immunization with recombinant gp160 human immunodeficiency virus (HIV) envelope protein in early HIV-1 infection: evaluation of the T cell proliferative response.

Ratto-Kim S, Sitz KV, Garner RP, Kim JH, Davis C, Aronson N, Ruiz N, Tencer K, Redfield RR, Birx DL. Ratto-Kim S, et al. J Infect Dis. 1999 Feb;179(2):337-44. doi: 10.1086/314587. J Infect Dis. 1999. PMID: 9878016 Clinical Trial.

6

Efficacy testing of recombinant human immunodeficiency virus (HIV) gp160 as a therapeutic vaccine in early-stage HIV-1-infected volunteers. rgp160 Phase II Vaccine Investigators.

Birx DL, Loomis-Price LD, Aronson N, Brundage J, Davis C, Deyton L, Garner R, Gordin F, Henry D, Holloway W, Kerkering T, Luskin-Hawk R, McNeil J, Michael N, Foster Pierce P, Poretz D, Ratto-Kim S, Renzullo P, Ruiz N, Sitz K, Smith G, Tacket C, Thompson M, Tramont E, Yangco B, Yarrish R, Redfield RR. Birx DL, et al. J Infect Dis. 2000 Mar;181(3):881-9. doi: 10.1086/315308. J Infect Dis. 2000. PMID: 10720508 Clinical Trial.

7

Comparison of HIV-1 envelope-specific CD4+ T cell lines simultaneously established from peripheral blood mononuclear cells and lymph node biopsy in HIV-1-infected individuals.

Ratto-Kim S, Sitz KV, Scherer AM, Kim JH, Anderson DW, Nau ME, Mann DL, Akolkar PN, Gulwani-Akolkar B, Silver J, Birx DL. Ratto-Kim S, et al. J Immunol. 1997 Nov 15;159(10):5162-7. J Immunol. 1997. PMID: 9366447

8

Selective increases in HIV-specific neutralizing antibody and partial reconstitution of cellular immune responses during prolonged, successful drug therapy of HIV infection.

Kim JH, Mascola JR, Ratto-Kim S, VanCott TC, Loomis-Price L, Cox JH, Michael NL, Jagodzinski L, Hawkes C, Mayers D, Gilliam BL, Birx DC, Robb ML. Kim JH, et al. AIDS Res Hum Retroviruses. 2001 Jul 20;17(11):1021-34. doi: 10.1089/088922201300343708. AIDS Res Hum Retroviruses. 2001. PMID: 11485619

9

Safety and Immunogenicity of a Randomized Phase 1 Prime-Boost Trial With ALVAC-HIV (vCP205) and Oligomeric Glycoprotein 160 From HIV-1 Strains MN and LAI-2 Adjuvanted in Alum or Polyphosphazene.

O'Connell RJ, Excler JL, Polonis VR, Ratto-Kim S, Cox J, Jagodzinski LL, Liu M, Wieczorek L, McNeil JG, El-Habib R, Michael NL, Gilliam BL, Paris R, VanCott TC, Tomaras GD, Birx DL, Robb ML, Kim JH. O'Connell RJ, et al. J Infect Dis. 2016 Jun 15;213(12):1946-54. doi: 10.1093/infdis/jiw059. Epub 2016 Feb 11. J Infect Dis. 2016. PMID: 26908741 Free PMC article. Clinical Trial.

10

Immune reconstitution following autologous transfers of CD3/CD28 stimulated CD4(+) T cells to HIV-infected persons.

Bernstein WB, Cox JH, Aronson NE, Tracy L, Schlienger K, Ratto-Kim S, Garner R, Cotte J, Zheng Z, Winestone L, Liebig C, Galley LM, Connors M, Birx DL, Carroll RG, Levine BL. Bernstein WB, et al. Clin Immunol. 2004 Jun;111(3):262-74. doi: 10.1016/j.clim.2004.03.004. Clin Immunol. 2004. PMID: 15183147

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

66 results

Search Page